GSA Capital Partners’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Buy |
9,548
+5,860
| +159% | +$751K | 0.09% | 339 |
|
|
2025
Q1 | $326K | Buy |
+3,688
| New | +$326K | 0.03% | 1086 |
|
|
2024
Q3 | – | Sell |
-7,444
| Closed | -$802K | – | 1613 |
|
|
2024
Q2 | $802K | Buy |
+7,444
| New | +$802K | 0.06% | 661 |
|
|
2023
Q4 | – | Sell |
-11,845
| Closed | -$595K | – | 1521 |
|
|
2023
Q3 | $595K | Buy |
+11,845
| New | +$595K | 0.05% | 685 |
|
|
2023
Q1 | – | Sell |
-18,168
| Closed | -$796K | – | 1502 |
|
|
2022
Q4 | $796K | Buy |
+18,168
| New | +$796K | 0.1% | 326 |
|
|
2021
Q4 | – | Sell |
-4,908
| Closed | -$505K | – | 1422 |
|
|
2021
Q3 | $505K | Sell |
4,908
-5,555
| -53% | -$572K | 0.05% | 692 |
|
|
2021
Q2 | $920K | Buy |
+10,463
| New | +$920K | 0.1% | 288 |
|
|
2021
Q1 | – | Sell |
-4,973
| Closed | -$558K | – | 1114 |
|
|
2020
Q4 | $558K | Buy |
+4,973
| New | +$558K | 0.09% | 362 |
|
|
2019
Q4 | – | Sell |
-4,301
| Closed | -$316K | – | 1443 |
|
|
2019
Q3 | $316K | Buy |
+4,301
| New | +$316K | 0.04% | 857 |
|